Expanded liability for generic, brand manufacturers ahead? To what extent are generics companies obligated by law to request labeling changes with FDA? The Supreme Court is expected to decide this summer

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmaceutical executive 2011-05, Vol.31 (5), p.36
1. Verfasser:	Brenner, John F
Format:	Magazinearticle
Sprache:	eng
Schlagworte:	Attorneys Liability (Law) Pharmaceutical industry
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue	5
container_start_page	36
container_title	Pharmaceutical executive
container_volume	31
creator	Brenner, John F
description
format	Magazinearticle
fullrecord	<record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_businessinsightsgauss_A260285890</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A260285890</galeid><sourcerecordid>A260285890</sourcerecordid><originalsourceid>FETCH-gale_businessinsightsgauss_A2602858903</originalsourceid><addsrcrecordid>eNqVjU1OAzEMhWcBEuXnDj5AK0Wl005XqCqt2NN95WQ8iVEmM8SJpj0jlyJIcAA2frL93vduqplabraLdb1Rd9W9yIdSarWqm1n1dbiMGFpqwTNq9pyu0A0RLAWKbOagY3lDjyF3aFKOFAXQEbYvcBpgcpiALolCAoz0FxMwQ1-4TAKD9mwxlQZ9BY8TpAEifWaSVFZNnoMF4zDYYp44OTi-7grcEbznMVJPsB9yTMBSmkYyP6jCaMlwS5BcuUvue4qP1W2HXujpVx-q-fFw2r8tLHo66ywcSMoQti6JxSxy3i3XatnUzVY9_9P-DSpVcvI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>magazinearticle</recordtype></control><display><type>magazinearticle</type><title>Expanded liability for generic, brand manufacturers ahead? To what extent are generics companies obligated by law to request labeling changes with FDA? The Supreme Court is expected to decide this summer</title><source>Business Source Complete</source><creator>Brenner, John F</creator><creatorcontrib>Brenner, John F</creatorcontrib><identifier>ISSN: 0279-6570</identifier><language>eng</language><publisher>Intellisphere, LLC</publisher><subject>Attorneys ; Liability (Law) ; Pharmaceutical industry</subject><ispartof>Pharmaceutical executive, 2011-05, Vol.31 (5), p.36</ispartof><rights>COPYRIGHT 2011 Intellisphere, LLC</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,784</link.rule.ids></links><search><creatorcontrib>Brenner, John F</creatorcontrib><title>Expanded liability for generic, brand manufacturers ahead? To what extent are generics companies obligated by law to request labeling changes with FDA? The Supreme Court is expected to decide this summer</title><title>Pharmaceutical executive</title><subject>Attorneys</subject><subject>Liability (Law)</subject><subject>Pharmaceutical industry</subject><issn>0279-6570</issn><fulltext>true</fulltext><rsrctype>magazinearticle</rsrctype><creationdate>2011</creationdate><recordtype>magazinearticle</recordtype><sourceid>N95</sourceid><recordid>eNqVjU1OAzEMhWcBEuXnDj5AK0Wl005XqCqt2NN95WQ8iVEmM8SJpj0jlyJIcAA2frL93vduqplabraLdb1Rd9W9yIdSarWqm1n1dbiMGFpqwTNq9pyu0A0RLAWKbOagY3lDjyF3aFKOFAXQEbYvcBpgcpiALolCAoz0FxMwQ1-4TAKD9mwxlQZ9BY8TpAEifWaSVFZNnoMF4zDYYp44OTi-7grcEbznMVJPsB9yTMBSmkYyP6jCaMlwS5BcuUvue4qP1W2HXujpVx-q-fFw2r8tLHo66ywcSMoQti6JxSxy3i3XatnUzVY9_9P-DSpVcvI</recordid><startdate>20110501</startdate><enddate>20110501</enddate><creator>Brenner, John F</creator><general>Intellisphere, LLC</general><scope>N95</scope><scope>XI7</scope></search><sort><creationdate>20110501</creationdate><title>Expanded liability for generic, brand manufacturers ahead? To what extent are generics companies obligated by law to request labeling changes with FDA? The Supreme Court is expected to decide this summer</title><author>Brenner, John F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_businessinsightsgauss_A2602858903</frbrgroupid><rsrctype>magazinearticle</rsrctype><prefilter>magazinearticle</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Attorneys</topic><topic>Liability (Law)</topic><topic>Pharmaceutical industry</topic><toplevel>online_resources</toplevel><creatorcontrib>Brenner, John F</creatorcontrib><collection>Gale Business: Insights</collection><collection>Business Insights: Essentials</collection><jtitle>Pharmaceutical executive</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brenner, John F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expanded liability for generic, brand manufacturers ahead? To what extent are generics companies obligated by law to request labeling changes with FDA? The Supreme Court is expected to decide this summer</atitle><jtitle>Pharmaceutical executive</jtitle><date>2011-05-01</date><risdate>2011</risdate><volume>31</volume><issue>5</issue><spage>36</spage><pages>36-</pages><issn>0279-6570</issn><pub>Intellisphere, LLC</pub></addata></record>
fulltext	fulltext
identifier	ISSN: 0279-6570
ispartof	Pharmaceutical executive, 2011-05, Vol.31 (5), p.36
issn	0279-6570
language	eng
recordid	cdi_gale_businessinsightsgauss_A260285890
source	Business Source Complete
subjects	Attorneys Liability (Law) Pharmaceutical industry
title	Expanded liability for generic, brand manufacturers ahead? To what extent are generics companies obligated by law to request labeling changes with FDA? The Supreme Court is expected to decide this summer
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T22%3A01%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expanded%20liability%20for%20generic,%20brand%20manufacturers%20ahead?%20To%20what%20extent%20are%20generics%20companies%20obligated%20by%20law%20to%20request%20labeling%20changes%20with%20FDA?%20The%20Supreme%20Court%20is%20expected%20to%20decide%20this%20summer&rft.jtitle=Pharmaceutical%20executive&rft.au=Brenner,%20John%20F&rft.date=2011-05-01&rft.volume=31&rft.issue=5&rft.spage=36&rft.pages=36-&rft.issn=0279-6570&rft_id=info:doi/&rft_dat=%3Cgale%3EA260285890%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A260285890&rfr_iscdi=true